NSETrading Window28 Sept 2026 · 28 Sept 2026, 04:57 pm

Trading Window

CORONA Remedies Limited · CORONA

✦ AI Summary

CORONA Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

CORONA Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

CORONAREMEDIES_28092026165713_Intimation_for_closure_of_Trading_Window.pdf

pdf

Download →
View document text
September 28, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai- 400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Intimation of Closure of Trading Window for dealing in securities of CORONA Remedies Limited (Company) in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 This is to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended and the Code of Conduct for Regulating, Monitoring and Reporting of Insider Trading in the Securities of the Company, the Trading Window for dealing in the securities of the Company shall remain closed with effect from October 01, 2026 until 48 hours from the declaration of the unaudited financial results of the Company for the second quarter and half year ending on September 30, 2026. The date of Board Meeting, inter alia, to consider the unaudited financial results for the second quarter and half year ending on September 30, 2026 will be intimated separately in due course. You are requested to take note of the above. Thanking you. Yours faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer